Literature DB >> 26543814

A subtle case of tuberous sclerosis complex.

Hitoshi Nakano1, Atsushi Otsuka2, Masako Kinoshita3.   

Abstract

Tuberous sclerosis complex (TSC) is known to cause severe intractable epilepsy and mental retardation; however, diagnosis can be delayed in milder cases. We report a 26-year-old right-handed female patient who started having convulsions at age 7 days. She had several focal seizures per year that were intractable to treatment with carbamazepine or phenytoin. Her two sisters had several episodes of suspected epileptic seizures but had no symptoms related to TSC. Seizure semiology of the patient comprised of visual hallucination, loss of consciousness, and convulsive movements predominantly on the right. Physical examination revealed several small scattered angiofibromas over the nose that were histologically determined by skin biopsy. Hypomelanotic macules, shagreen patches, or periungual fibromas were not seen. Neurological examination showed mental retardation (MMSE: 23/30, WAIS-III: VIQ63, PIQ59, FIQ58) and decreased vibration sensation in both legs. Interictal EEG showed slow waves and epileptiform discharges broadly over the anterior quadrants bilaterally. Brain imaging showed multiple cortical tubers and malformation of cortical development but no subependymal nodules. Interictal IMP-SPECT showed hypoperfusion in the left frontal lobe. Cardiac rhabdomyoma was not noticed by cardiac echography. Truncal CT showed sclerosis of the bilateral lumbosacral joints. There was no abnormality in the lung, major arteries, liver, or kidneys. No hamartomas or retinal achromic patches were noticed by ophthalmologic evaluation. Administration of lamotrigine was effective for her seizures. This patient fulfilled two major features of diagnostic criteria for TSC and was diagnosed as definite TSC. Patients with mental retardation and epilepsy should be carefully evaluated for the possible diagnosis of TSC.

Entities:  

Keywords:  Angiofibromas; Cortical tubers; Epilepsy; Subependymal nodules; Tuberous sclerosis complex

Year:  2015        PMID: 26543814      PMCID: PMC4589839          DOI: 10.1016/j.ebcr.2015.08.002

Source DB:  PubMed          Journal:  Epilepsy Behav Case Rep        ISSN: 2213-3232


Introduction

Tuberous sclerosis complex (TSC) is a multisystem, autosomal dominant disorder with an incidence of approximately 1 in 6000 live births [1]. Tuberous sclerosis complex usually manifests itself in early life with severe intractable epilepsy and mental retardation; however, diagnosis can be delayed in milder cases. A recent study demonstrated the importance of early diagnosis and commencement of preventative antiepileptic treatment of infants with TSC to improve neurodevelopmental and seizure outcomes [2]. Here, we present a patient with TSC with subtle cardinal manifestations. Part of this manuscript was presented at the 10th Asian & Oceanian Epilepsy Congress, Singapore 2014 and appeared in an abstract form [3].

Case report

A 26-year-old right-handed woman presented for a thorough evaluation of seizures that were not controlled by medical therapy. She started having convulsions at age 7 days and had several focal seizures per year that were intractable to treatment with carbamazepine or phenytoin. Her two sisters had several episodes of suspected epileptic seizures. Her elder sister had fainting attacks probably caused by anemia. Her younger sister developed generalized convulsions when she was in high school, was treated with antiepileptic medication, and, after finishing therapy, has been seizure-free for more than 2 years. Both were examined in other hospitals, and no symptom related to TSC was reported. Seizure semiology of the patient comprised of visual hallucination, loss of consciousness, and convulsive movements predominantly on the right side. Therefore we categorized her seizures as focal without initial impairment of consciousness evolving to impaired consciousness and then to bilateral convulsive seizures. Physical examination revealed several small scattered angiofibromas over the nose (Fig. 1) that were histologically determined by skin biopsy (Fig. 2). Hypomelanotic macules, shagreen patches, or periungual fibromas were not seen. Neurological examination showed mental retardation (MMSE: 23/30, WAIS-III: VIQ 63, PIQ 59, FIQ 58) and decreased vibration sensation in both legs. Interictal EEG showed slow waves and epileptiform discharges broadly over the anterior quadrants bilaterally (Fig. 3). Brain imaging showed multiple cortical tubers and malformation of cortical development in the left cerebral hemisphere but no subependymal nodules or other calcified lesions (Fig. 4). Interictal IMP-SPECT showed hypoperfusion in the left frontal lobe (Fig. 4). Truncal CT showed sclerosis of the bilateral lumbosacral joints (Fig. 5). Cardiac rhabdomyoma was not noticed by cardiac echography. There was no abnormality of the lung, major arteries, liver, or kidneys. No hamartomas or retinal achromic patches were noticed by ophthalmologic evaluation. Administration of lamotrigine was effective for her seizures.
Fig. 1

Several small angiofibromas over the nose in a 26-year-old woman.

Fig. 2

A dome-shaped angiofibroma in the superficial dermis, showing a proliferation of stellate and spindled cells around blood vessels and concentric collagen bundles.

Fig. 3

Interictal EEG. Slow waves and epileptiform discharges broadly over the anterior quadrants bilaterally.

Fig. 4

Axial views of CT, FLAIR MRI, and interictal IMP-SPECT almost at the same level. Note malformation of cortical development and hypoperfusion in the left frontal lobe (arrow). No subependymal nodules or other calcified lesions were seen on CT.

Fig. 5

Sclerosis of bilateral lumbosacral joints in truncal CT (arrows).

Discussion

This patient fulfilled two major diagnostic criteria for TSC, i.e., facial angiofibromas and cortical tubers, and was diagnosed as having definite TSC [4]. This patient’s epilepsy was categorized into epilepsies attributed to and organized by structural-metabolic causes, neurocutaneous syndromes, and TSC. She was devoid of calcified subependymal nodules which are known to be one of the most common features of TSC. Approximately 90% of patients have subependymal nodules in epidemiological studies among patient populations with TSC, and mainly in children (mean age of 10–11 years) [5,6], compared with 77% among those in adults (mean age of 27 years) [7]. Early recognition of TSC is important to understand the course of the disease and possible strategies to prevent progression [2].

Conclusion

Patients with mental retardation and epilepsy should be carefully evaluated for the possible diagnosis of TSC, even if they lack subependymal nodules or show mild skin symptoms.

Conflict of interest

The authors declare that they have no conflict of interest.
  6 in total

1.  Non-penetrance in tuberous sclerosis.

Authors:  J P Osborne; A C Jones; M W Burley; D Jeganathan; J Young; F J O'Callaghan; J R Sampson; S Povey
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

2.  Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.

Authors:  Ozgur Sancak; Mark Nellist; Miriam Goedbloed; Peter Elfferich; Cokkie Wouters; Anneke Maat-Kievit; Bernard Zonnenberg; Senno Verhoef; Dicky Halley; Ans van den Ouweland
Journal:  Eur J Hum Genet       Date:  2005-06       Impact factor: 4.246

3.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

4.  Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex.

Authors:  Sergiusz Jóźwiak; Katarzyna Kotulska; Dorota Domańska-Pakieła; Barbara Lojszczyk; Małgorzata Syczewska; Dariusz Chmielewski; Dorota Dunin-Wąsowicz; Tomasz Kmieć; Joanna Szymkiewicz-Dangel; Maria Kornacka; Wanda Kawalec; Dariusz Kuczyński; Julita Borkowska; Katarzyna Tomaszek; Elżbieta Jurkiewicz; Maria Respondek-Liberska
Journal:  Eur J Paediatr Neurol       Date:  2011-04-19       Impact factor: 3.140

Review 5.  Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria.

Authors:  E S Roach; M R Gomez; H Northrup
Journal:  J Child Neurol       Date:  1998-12       Impact factor: 1.987

6.  Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients.

Authors:  Mari Wataya-Kaneda; Mari Tanaka; Toshimitsu Hamasaki; Ichiro Katayama
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

  6 in total
  2 in total

1.  Incidental diagnosis of tuberous sclerosis complex by exome sequencing in three families with subclinical findings.

Authors:  R C Caylor; L Grote; I Thiffault; E G Farrow; L Willig; S Soden; S M Amudhavalli; A J Nopper; K A Horii; E Fleming; J Jenkins; H Welsh; M Ilyas; K Engleman; A Abdelmoity; C J Saunders
Journal:  Neurogenetics       Date:  2018-06-20       Impact factor: 2.660

2.  Update of Clown Nose-Like Lesion, a Underrecognized Manifestation of Metastatic Malignancies and Genetic Cancer Predisposition Syndromes.

Authors:  Bei Zhao; Ling Chen; Jinfeng Liao; Zhen Xie; Xia Lei; Zhu Shen
Journal:  Front Med (Lausanne)       Date:  2021-05-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.